683 Capital Management’s ProMIS Neurosciences PMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.71M Buy
250,000
+155,000
+163% +$2.11M 0.11% 93
2026
Q2
$1.25M Buy
95,000
+2,150
+2% +$23.3K 0.06% 120
2026
Q1
$1.18M Buy
+92,850
New +$1.38M 0.06% 133

Other funds holding PMN

683 Capital Management's PMN Position: Q3 2026 in Review

683 Capital Management increased its ProMIS Neurosciences (PMN) stake by 163% in Q3 2026, buying an estimated $2.11M and bringing the position to 250,000 shares worth $2.71M. The position accounts for 0.11% of the portfolio, ranked #93.

683 Capital Management first reported a position in PMN in Q1 2026 and has held it in 3 quarters since. 30 funds tracked by Wall St. Rank hold PMN as of Q3 2026.

  • 683 Capital Management held 250,000 shares of ProMIS Neurosciences worth $2.71M as of Q3 2026.
  • 683 Capital Management bought 155,000 ProMIS Neurosciences shares in Q3 2026, an estimated $2.11M.
  • ProMIS Neurosciences made up 0.11% of 683 Capital Management's portfolio in Q3 2026, its #93 holding.
  • 683 Capital Management first reported a position in ProMIS Neurosciences in Q1 2026 and has held it in 3 quarters since.
  • 30 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2026.

Based on 683 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.